Form 4: Great Southern Bancorp Executive Rex A. Copeland Executes Option, Sells Shares

Sentiment:

SEC Form 4 Filing


Rex A. Copeland, a Senior Vice President of a subsidiary and Treasurer at Great Southern Bancorp, exercised stock options and sold shares on November 6, 2024.

Summary

  • On November 6, 2024, Rex A. Copeland, a Senior Vice President of Subsidiary and Treasurer at Great Southern Bancorp, exercised options to purchase 4,200 shares of common stock at a price of $50.71.
  • Following the exercise of the options, Copeland sold 4,200 shares of common stock at a price of $66.5898.
  • After these transactions, Copeland directly owns 22,268 shares of Great Southern Bancorp common stock.
  • Copeland also holds options to purchase a total of 30,850 additional shares at prices ranging from $41.3 to $61.55, which vest in installments through November 16, 2032.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions. It provides transparency into the trading activities of company executives, which is important for investors in the financial services sector.

Comparison to Industry Standards

  • Executive compensation practices, including stock options, are common in the banking industry to align management's interests with those of shareholders.
  • Comparable companies such as Commerce Bancshares (CBSH) and UMB Financial Corporation (UMBF) also utilize stock options as part of their executive compensation packages.
  • The vesting schedules and exercise prices of these options are generally in line with industry standards for incentivizing long-term performance.

Stakeholder Impact

  • Shareholders may view insider transactions as a signal of management's confidence (or lack thereof) in the company's future performance.
  • The exercise of options and subsequent sale of shares can have a minor dilutive effect on existing shareholders.

Key Dates

DateDescription
11/18/2017Initial vesting date for 1,050 shares related to one of the options.
10/24/2018Initial vesting date for 1,050 shares related to one of the options.
11/15/2019Initial vesting date for 1,050 shares related to one of the options.
11/28/2020Initial vesting date for 1,050 shares related to one of the options.
11/20/2021Initial vesting date for 1,050 shares related to one of the options.
10/26/2022Initial vesting date for 1,125 shares related to one of the options.
11/17/2023Initial vesting date for 1,188 shares related to one of the options.
11/06/2024Date of transaction: option exercise and share sale.
11/08/2024Date of signature on the form.
11/16/2024Initial vesting date for 1,200 shares related to one of the options.
10/26/2025Final vesting date for 1,125 shares related to one of the options.
11/17/2026Final vesting date for 1,187 shares related to one of the options.
11/16/2027Final vesting date for 1,200 shares related to one of the options.
11/20/2029Expiration date for one of the options.
10/26/2030Expiration date for one of the options.
11/17/2031Expiration date for one of the options.
11/16/2032Expiration date for one of the options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.